US20080269153A1
(en)
*
|
2002-05-28 |
2008-10-30 |
Ruxandra Draghia-Akli |
Increased stability of a dna formulation by including poly-l-glutamate
|
US7846720B2
(en)
*
|
2005-01-26 |
2010-12-07 |
Vgx Pharmaceuticals, Inc. |
Optimized high yield synthetic plasmids
|
CA2604452C
(en)
*
|
2005-04-18 |
2018-03-13 |
Francine Behar-Cohen |
Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
|
FR2893256B1
(fr)
*
|
2005-11-14 |
2008-08-15 |
Yves Scherman |
Generateur d'impulsions electriques unipolaires.
|
EP1981581B1
(en)
*
|
2006-02-11 |
2016-04-13 |
Genetronics, Inc. |
Device for single-needle in vivo electroporation
|
DE102006009157B4
(de)
*
|
2006-02-24 |
2015-08-20 |
Eisenmann Ag |
Verfahren zum Aufschließen von biologischem Material sowie Vorrichtung zu seiner Durchführung
|
JP2009528131A
(ja)
*
|
2006-03-03 |
2009-08-06 |
ジェネトロニクス,インコーポレイティド |
外科的切除後の組織に残る微視的残余腫瘍の処置方法及び装置
|
ATE451067T1
(de)
*
|
2006-06-12 |
2009-12-15 |
Region Hovedstaden V Herlev Ho |
Elektrodeneinführeinrichtung
|
US7576549B2
(en)
*
|
2006-09-21 |
2009-08-18 |
Bio-Rad Laboratories, Inc. |
Methods for measuring sample resistance in electroporation
|
PT2066399T
(pt)
*
|
2006-10-17 |
2019-01-11 |
Inovio Pharmaceuticals Inc |
Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
|
EP2799547B1
(en)
|
2006-11-08 |
2016-12-21 |
Veritas Bio, LLC |
In Vivo Delivery of RNA to a Target Cell
|
US20100247437A1
(en)
*
|
2007-10-01 |
2010-09-30 |
Vgx Pharmaceuticals, Llc |
Materials and methods for the delivery of biomolecules to cells of an organ
|
AU2008331673B2
(en)
*
|
2007-11-12 |
2014-12-11 |
The Trustees Of The University Of Pennsylvania |
Novel vaccines against multiple subtypes of influenza virus
|
CA2702971C
(en)
*
|
2007-11-14 |
2023-03-14 |
Vgx Pharmaceuticals, Llc |
Antibody production elicited by a dna vaccine delivered by electroporation
|
KR101686942B1
(ko)
|
2008-01-11 |
2016-12-28 |
이노비오 파마수티컬즈, 인크. |
뎅기 바이러스 다중 서브타입에 대항하는 신규한 백신
|
WO2009124312A2
(en)
*
|
2008-04-04 |
2009-10-08 |
The Trustees Of The University Of Pennsylvania |
Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
|
WO2009124309A2
(en)
*
|
2008-04-04 |
2009-10-08 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
|
JP5963442B2
(ja)
|
2008-05-28 |
2016-08-03 |
ブイジーエックス ファーマシューティカルズ, エルエルシー |
免疫応答を誘発する天然痘dnaワクチンおよびその中の抗原
|
JP5753090B2
(ja)
|
2008-10-29 |
2015-07-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
改良型hcvワクチンおよびその使用方法
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
EP2358733B1
(en)
*
|
2008-11-17 |
2015-07-08 |
Inovio Pharmaceuticals, Inc. |
Antigens that elicit immune response against flavivirus and methods of using same
|
TWI423790B
(zh)
*
|
2008-11-18 |
2014-01-21 |
Univ Nat Chiao Tung |
可調式電極植入系統及其可調式電極植入裝置
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
EP2498814B1
(en)
|
2009-11-02 |
2015-09-09 |
The Trustees of the University of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
AU2011213559B2
(en)
|
2010-02-08 |
2015-05-07 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding RANTES, and compositions comprising and methods of using the same
|
CN110195069A
(zh)
|
2010-09-27 |
2019-09-03 |
宾夕法尼亚大学托管会 |
共有抗原构建体和由其制备的疫苗以及使用所述疫苗治疗疟疾的方法
|
EP3536703B1
(en)
|
2010-11-12 |
2021-05-26 |
The Trustees of the University of Pennsylvania |
Consensus prostate antigens, nucleic acid molecules encoding the same and uses thereof
|
TR201904239T4
(tr)
|
2011-01-28 |
2019-05-21 |
Massachusetts Gen Hospital |
Süreksiz dermabrazyona yönelik yöntem ve aparat.
|
CN103547226B
(zh)
|
2011-01-28 |
2018-04-17 |
通用医疗公司 |
用于皮肤再表面化的装置
|
WO2012103483A2
(en)
|
2011-01-28 |
2012-08-02 |
The General Hospital Corporation |
Apparatus and method for tissue biopsy
|
US9243041B2
(en)
|
2011-01-31 |
2016-01-26 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
|
CA2827080C
(en)
|
2011-02-11 |
2022-09-20 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
ITTO20110374A1
(it)
*
|
2011-04-29 |
2012-10-30 |
Igea S P A |
Metodo di controllo di un dispositivo di elettro-porazione
|
AU2012321315B2
(en)
|
2011-07-11 |
2016-04-14 |
Inovio Pharmaceuticals, Inc |
Cross-protective arenavirus vaccines and their method of use
|
AU2012321317B2
(en)
|
2011-07-12 |
2016-01-28 |
Inovio Pharmaceuticals, Inc |
Novel clostridium difficile DNA vaccine
|
HUE042454T2
(hu)
|
2011-07-21 |
2019-07-29 |
Massachusetts Gen Hospital |
Berendezés zsír roncsolására és eltávolítására
|
SG11201400527XA
(en)
|
2011-09-16 |
2014-04-28 |
Univ Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
US9708384B2
(en)
|
2011-09-22 |
2017-07-18 |
The Trustees Of The University Of Pennsylvania |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
|
EP3443982A1
(en)
|
2011-10-12 |
2019-02-20 |
The Trustees of the University of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
KR101913674B1
(ko)
|
2011-10-24 |
2018-10-31 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 hcv 백신 및 이것을 사용하는 방법
|
US9272002B2
(en)
|
2011-10-28 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
BR112014014078A2
(pt)
|
2011-12-12 |
2018-10-09 |
The Trustees Of The University Of Pennsylvania |
composições compreendendo constructos genéticos il-12 aperfeiçoados e vacinas, imunoterapêuticos e métodos de uso dos mesmos
|
KR20140116095A
(ko)
|
2011-12-12 |
2014-10-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Mrsa pbp2a 및 이의 단편들을 포함하는 단백질, 이를 인코딩한 핵산, 및 mrsa 감염을 예방 및 치료하기 위한 조성물 및 그의 용도
|
JP2015509717A
(ja)
|
2012-02-22 |
2015-04-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
抗腫瘍活性およびcar存続性を強化するためのicosベースのcarの使用
|
CA2864489C
(en)
|
2012-02-22 |
2023-08-08 |
The Trustees Of The University Of Pennsylvania |
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
|
AU2013245950B2
(en)
|
2012-04-10 |
2016-04-21 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
KR102146904B1
(ko)
|
2012-04-12 |
2020-08-24 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법
|
CA2876730A1
(en)
|
2012-07-13 |
2014-01-16 |
The Trustees Of The University Of Pennsylvania |
Enhancing activity of car t cells by co-introducing a bispecific antibody
|
US9365641B2
(en)
|
2012-10-01 |
2016-06-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting stromal cells for the treatment of cancer
|
WO2014055771A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
WO2014055657A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
EP2911736A4
(en)
*
|
2012-10-25 |
2016-06-15 |
Oncosec Medical Inc |
electroporation
|
WO2014093897A1
(en)
|
2012-12-13 |
2014-06-19 |
The Trustees Of The University Of Pennsylvania |
Wt1 vaccine
|
WO2015089492A2
(en)
|
2013-12-13 |
2015-06-18 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
US10543127B2
(en)
|
2013-02-20 |
2020-01-28 |
Cytrellis Biosystems, Inc. |
Methods and devices for skin tightening
|
CN105307678A
(zh)
|
2013-03-12 |
2016-02-03 |
宾夕法尼亚大学理事会 |
用于人乳头状瘤病毒的改进疫苗及其使用方法
|
US11419925B2
(en)
|
2013-03-15 |
2022-08-23 |
The Trustees Of The University Of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
CN114045295A
(zh)
|
2013-03-15 |
2022-02-15 |
宾夕法尼亚大学理事会 |
口蹄疫病毒(fmdv)共有蛋白、其编码序列以及由其制造的疫苗
|
US11013917B2
(en)
|
2013-06-21 |
2021-05-25 |
Newsouth Innovations Pty Limited |
Method and apparatus for close-field electroporation
|
KR102349218B1
(ko)
|
2013-08-09 |
2022-01-10 |
사이트렐리스 바이오시스템즈, 인크. |
비-열적 조직 절제를 사용한 피부 치료를 위한 방법 및 기구
|
CN203451533U
(zh)
*
|
2013-08-27 |
2014-02-26 |
苏州文曲生物微系统有限公司 |
一种基于新型微电极芯片的电穿孔系统
|
WO2015095675A1
(en)
|
2013-12-19 |
2015-06-25 |
Cytrellis Biosystems, Inc. |
Methods and devices for manipulating subdermal fat
|
US11028143B2
(en)
|
2014-01-21 |
2021-06-08 |
Novartis Ag |
Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules
|
ES2910227T3
(es)
|
2014-10-31 |
2022-05-12 |
Univ Pennsylvania |
Composición y métodos para la estimulación y expansión de células T
|
MX2017005698A
(es)
|
2014-10-31 |
2017-06-29 |
Univ Pennsylvania |
Alteracion de la expresion genetica en celulas t modificadas con el receptor de antigeno quimerico (cart) y usos de las mismas.
|
KR102670286B1
(ko)
|
2014-11-14 |
2024-05-30 |
사이트렐리스 바이오시스템즈, 인크. |
피부 절제를 위한 디바이스 및 방법
|
AU2015355126B9
(en)
|
2014-12-01 |
2020-03-26 |
Inovio Pharmaceuticals, Inc. |
DNA antibody constructs and method of using same
|
CA2973390A1
(en)
|
2015-01-09 |
2016-07-14 |
Oncosec Medical Incorporated |
Method for the treatment of malignancies
|
JP7170394B2
(ja)
|
2015-01-31 |
2022-11-14 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
治療用分子のt細胞送達のための組成物および方法
|
JP6879996B2
(ja)
|
2015-03-26 |
2021-06-02 |
オンコセック メディカル インコーポレイテッド |
悪性腫瘍の治療方法
|
PL3277368T3
(pl)
*
|
2015-03-31 |
2021-01-25 |
Oncosec Medical Incorporated |
Układy do ulepszonej elektroporacji opartej na wykrywaniu tkanek
|
WO2016178996A1
(en)
|
2015-05-01 |
2016-11-10 |
The Regents Of The University Of California |
Glycan-dependent immunotherapeutic molecules
|
WO2016205895A1
(en)
*
|
2015-06-25 |
2016-12-29 |
Newsouth Innovations Pty Limited |
Electroporation system for controlled localized therapeutics delivery
|
EP3340998B1
(en)
|
2015-08-28 |
2023-01-11 |
The Trustees of the University of Pennsylvania |
Methods and compositions for cells expressing a chimeric intracellular signaling molecule
|
KR101788301B1
(ko)
*
|
2015-09-17 |
2017-10-20 |
주식회사 엘림텍 |
전기천공장치 및 그 제어방법
|
AU2016369608B2
(en)
|
2015-12-18 |
2023-02-02 |
Jean Campbell |
Plasmid constructs for heterologous protein expression and methods of use
|
IL260071B2
(en)
*
|
2015-12-22 |
2023-03-01 |
Inovio Pharmaceuticals Inc |
An electroporation device that includes a battery pack with a power switch
|
BR112018015893A2
(pt)
|
2016-02-05 |
2019-03-06 |
Inovio Pharmaceuticals Inc |
vacinas de câncer e métodos de tratamento usando as mesmas
|
EP3432924A1
(en)
|
2016-03-23 |
2019-01-30 |
Novartis AG |
Cell secreted minibodies and uses thereof
|
KR20230117470A
(ko)
|
2016-03-29 |
2023-08-08 |
사이트렐리스 바이오시스템즈, 인크. |
미용 피부 리설페이싱용 디바이스 및 방법
|
EP3443107A1
(en)
|
2016-04-13 |
2019-02-20 |
Synthetic Genomics, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
JP2018035137A
(ja)
|
2016-07-13 |
2018-03-08 |
マブイミューン ダイアグノスティックス エイジーMabimmune Diagnostics Ag |
新規な抗線維芽細胞活性化タンパク質(fap)結合薬剤およびその使用
|
KR102515836B1
(ko)
|
2016-09-21 |
2023-03-31 |
사이트렐리스 바이오시스템즈, 인크. |
미용 피부 리설페이싱용 디바이스 및 방법
|
WO2018075235A1
(en)
|
2016-10-17 |
2018-04-26 |
Synthetic Genomics, Inc. |
Recombinant virus replicon systems and uses thereof
|
EP3548625B1
(en)
|
2016-12-05 |
2024-06-26 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for enhancing gene expression
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
SE541651C2
(en)
|
2017-07-28 |
2019-11-19 |
Scandinavian Chemotech Ab |
An electrode device and a needle electrode for use in delivery of electrical pulses to a desired tissue of a mammal
|
KR20230116954A
(ko)
|
2017-12-13 |
2023-08-04 |
이노비오 파마수티컬즈, 인크. |
Muc16을 표적화하는 암 백신 및 이의 용도
|
RU2751252C1
(ru)
|
2017-12-13 |
2021-07-12 |
Иновио Фармасьютикалз, Инк. |
Мезотелин-нацеленные вакцины от рака и их применение
|
MX2020006216A
(es)
|
2017-12-13 |
2020-08-31 |
Inovio Pharmaceuticals Inc |
Vacunas contra el cancer dirigidas a prame y sus usos.
|
KR20200100745A
(ko)
|
2017-12-19 |
2020-08-26 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(hbv)에 대한 면역 반응 유도를 위한 방법 및 조성물
|
KR20200101416A
(ko)
|
2017-12-19 |
2020-08-27 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(hbv) 백신 및 그 용도
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
US11021692B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B virus (HBV) vaccines and uses thereof
|
US11389531B2
(en)
|
2017-12-19 |
2022-07-19 |
Janssen Sciences Ireland Unlimited Company |
Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
|
JP7372920B2
(ja)
|
2017-12-29 |
2023-11-01 |
セレクティス |
Car t細胞の作製を改良するための方法
|
CN111902163B
(zh)
|
2018-01-19 |
2024-02-13 |
杨森制药公司 |
使用重组复制子系统诱导和增强免疫应答
|
US20220170097A1
(en)
|
2018-10-29 |
2022-06-02 |
The Broad Institute, Inc. |
Car t cell transcriptional atlas
|
US11185692B2
(en)
*
|
2018-10-31 |
2021-11-30 |
Emily Ireland |
Light touch therapeutic headset
|
US11071860B2
(en)
|
2019-02-06 |
2021-07-27 |
Oncosec Medical Incorporated |
Systems and methods for detecting fault conditions in electroporation therapy
|
US20220177863A1
(en)
|
2019-03-18 |
2022-06-09 |
The Broad Institute, Inc. |
Type vii crispr proteins and systems
|
TW202042824A
(zh)
|
2019-03-27 |
2020-12-01 |
賓夕法尼亞大學董事會 |
Tn-MUC1嵌合抗原受體(CAR)T細胞療法
|
US11660139B2
(en)
|
2019-04-10 |
2023-05-30 |
Radioclash Inc. |
Electroporation probe
|
CN109999340B
(zh)
*
|
2019-04-29 |
2024-07-16 |
杭州睿笛生物科技有限公司 |
一种负载自适应纳秒脉冲产生装置
|
CA3143679A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai
|
US20220324916A1
(en)
|
2019-06-18 |
2022-10-13 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B Virus (HBV) Vaccines and Uses Thereof
|
MA56523A
(fr)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Co |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'anticorps anti-pd-1 ou anti-pd-l1
|
WO2020255013A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives
|
WO2020255019A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
|
WO2020255038A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
EP3986562A1
(en)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai
|
CA3140588A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor
|
WO2020255014A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Recombinant interleukin 12 construct and uses thereof
|
WO2020255010A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines
|
WO2020255016A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
WO2020255035A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives
|
WO2020254876A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Virus-like particle delivery of hepatitis b virus (hbv) vaccines
|
US20220233684A1
(en)
|
2019-06-18 |
2022-07-28 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors
|
CA3143634A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 antibody
|
US20220241402A1
(en)
|
2019-06-18 |
2022-08-04 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives
|
CA3140702A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
CA3140690A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
WO2020255042A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative
|
US20220305116A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences lreland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivatives
|
WO2020255022A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors
|
WO2020255062A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
WO2020255063A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
|
CA3149494A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
JP2023516080A
(ja)
|
2020-03-06 |
2023-04-17 |
ジーオー セラピューティクス,インコーポレイテッド |
抗グリコcd44抗体およびその使用
|
WO2021191870A1
(en)
|
2020-03-27 |
2021-09-30 |
Dcprime B.V. |
Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
WO2021191871A1
(en)
|
2020-03-27 |
2021-09-30 |
Dcprime B.V. |
In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
AU2021289600A1
(en)
|
2020-06-12 |
2023-01-19 |
University Of Rochester |
Encoding and expression of ACE-tRNAs
|
JP2023533528A
(ja)
|
2020-07-08 |
2023-08-03 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
Hbvに対するrnaレプリコンワクチン
|
EP4210832A1
(en)
|
2020-09-14 |
2023-07-19 |
Vor Biopharma, Inc. |
Chimeric antigen receptors for treatment of cancer
|
AU2021375493A1
(en)
|
2020-11-05 |
2023-06-29 |
Mendus B.V. |
Use of tumor-independent antigens in immunotherapies
|
TW202245809A
(zh)
|
2020-12-18 |
2022-12-01 |
美商詹森藥物公司 |
用於治療b型肝炎病毒感染之組合療法
|
US20240316090A1
(en)
|
2020-12-28 |
2024-09-26 |
Arcturus Therapeutics, Inc. |
Transcription activator-like effector nucleases (talens) targeting hbv
|
JP2024512324A
(ja)
|
2021-03-05 |
2024-03-19 |
ジーオー セラピューティクス,インコーポレイテッド |
抗グリコcd44抗体およびその使用
|
JP2024510989A
(ja)
|
2021-03-12 |
2024-03-12 |
メンドゥス・ベスローテン・フェンノートシャップ |
ワクチン接種方法及びcd47遮断薬の使用
|
US20230001169A1
(en)
*
|
2021-06-30 |
2023-01-05 |
Inovio Pharmaceuticals, Inc. |
Electrode Arrays For Electroporation, and Related Systems and Methods
|
WO2023010118A1
(en)
|
2021-07-29 |
2023-02-02 |
Vor Biopharma Inc. |
Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same
|
EP4376877A2
(en)
|
2021-07-29 |
2024-06-05 |
Vor Biopharma Inc. |
Chimeric antigen receptors for treatment of cancer
|
EP4380604A1
(en)
|
2021-08-05 |
2024-06-12 |
Go Therapeutics, Inc. |
Anti-glyco-muc4 antibodies and their uses
|
TW202328188A
(zh)
|
2021-09-03 |
2023-07-16 |
美商Go治療公司 |
抗醣化-cmet抗體及其用途
|
CA3230933A1
(en)
|
2021-09-03 |
2023-03-09 |
Go Therapeutics, Inc. |
Anti-glyco-lamp1 antibodies and their uses
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2023215874A1
(en)
*
|
2022-05-05 |
2023-11-09 |
Renbio, Inc. |
Device related to therapeutic dna delivery
|
US20240002800A1
(en)
|
2022-05-16 |
2024-01-04 |
Mendus B.V. |
Use of leukemia-derived cells for enhancing natural killer (nk) cell therapy
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
WO2024129459A1
(en)
|
2022-12-16 |
2024-06-20 |
University Of Rochester |
Repairmen! of barrier dysfunction in esophagus
|